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ABSTRACT 
Aims; To study the prevalence of and describe factors associated with depressive symptoms and to 
observe the course in a cohort of elderly primary care patients with mild to moderate depression. To 
compare a structured patient-centered consultation model with a validated instrument when screening for 
depressive symptoms and to investigate if recommended cut-off values for a self-rated instrument should 
be adjusted for this population. 
Method; Cross-sectional data were collected for all papers from one observational two-year follow-up 
study, using questionnaires, interviews, consultations and medical records. Consecutive patients aged 60 
and up were screened for depressive symptoms at a primary care center in 2003. Included patients (n=302) 
completed the Primary Care Evaluation of Mental Disorders Patient Questionnaire (PRIME-MD PQ); the 
Montgomery-Åsberg Depression Rating Scale, self-rated version (MADRS-S); and a structured interview 
with a nurse. They then saw a general practitioner (GP) who assessed whether there was “possible 
depression”, with a structured patient-centered consultation model. The psychometric properties of the 
consultation model and the PRIME-MD PQ were calculated using the MADRS-S, at two cut-off levels, as 
a reference. The GPs performed a diagnostic interview using the PRIME-MD Clinical Evaluation Guide 
(CEG) with patients who had screened positive with any of the methods. In patients with mild to moderate 
depression (n=54), the course was observed during two years and risk factors and prognostic factors were 
studied. The optimal MADRS-S cut-off value for a depressive diagnosis was calculated by Receiver 
Operating Characteristic (ROC) curve. Logistic regression analysis was used for studying associations 
between the different variables and depressive symptoms as well as mild to moderate depression. 
Results Several psychosocial factors and somatic symptoms were associated with depressive symptoms. 
The point prevalence of depressive symptoms was 15 % (Paper I). The consultation model exhibited 
moderate to good properties for screening for depressive symptoms in the elderly (Paper II).While median 
MADRS-S scores declined during a two-year follow-up period, three course patterns were identified: 
remitting, stable, and fluctuating (Paper III). There were indications that the MADRS-S cut-off value 
should be lowered when screening for mild to moderate depression in this group (Paper IV). 
Conclusion Most elderly individuals with milder forms of depressive disorders are seen and treated in 
primary care. They are important to recognize since the conditions are associated with considerable 
functional disability and morbidity. A structured patient-centered consultation model, adjusting self-rated 
instruments’ cut-off values and knowledge of risk factors, prognostic factors, and course may be helpful 
for GPs in detecting, assessing, and managing depressive disorders in elderly primary care patients. 
Keywords: depressive symptoms, mild to moderate depression, patient-centered consultation, screening, 
elderly, primary care, course, longitudinal, risk factors, prognostic factors 
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SAMMANFATTNING PÅ SVENSKA 
Bakgrund: De flesta äldre individer med mild till måttlig depression 
omhändertas och behandlas i primärvården. De är viktiga att upptäcka 
eftersom de har en ökad risk för sjuklighet och dödlighet relaterat till 
självmord och kroppsliga sjukdomar. Idag finns det flera 
behandlingsalternativ med god effekt på både funktion och symtom. Syftet 
med forskningsprojektet var att jämföra en patientcentrerad 
konsultationsmodell med ett screeninginstrument och undersöka hur väl 
modellen fungerade för att upptäcka mild till måttlig depression i en äldre 
primärvårdspopulation. Förekomst och faktorer associerade med depressiva 
symtom och med diagnosen mild till måttlig depression studerades och 
depressionsförloppet observerades under två år. Optimalt tröskelvärde för ett 
självskattningsinstrument undersöktes också avseende mild till måttlig 
depression.  
Metod: Alla patienter, 60 år eller äldre, som besökte vårdcentralen 
tillfrågades oavsett besöksorsak att delta i studien. Före läkarbesöket 
intervjuades de av en sjuksköterska och fyllde i två depressionsfrågeformulär 
(PRIME-MD PQ och MADRS-S). Läkarna bedömde utifrån en etablerad 
patientcentrerad konsultationsmodell om patienten hade en ”möjlig 
depression”. Sensitivitet och specificitet för konsultationsmodellen jämfördes 
med PRIME-MD PQ med MADRS-S som referens. De patienter som 
screenade positivt med någon av metoderna bokades för återbesök och 
läkaren använde PRIME-MD CEG vid den kompletterande diagnostiska 
intervjun. Upprepade mätningar med MADRS-S gjordes under två år för att 
observera depressionsförloppet. Tvärsnittsdata från variabler hämtade ur 
frågeformulär, intervjuer, konsultationer och journaler analyserades för att 
beskriva associationer mellan dessa variabler och depressiva symtom 
respektive mild till måttlig depression. Det optimala tröskelvärdet för 
MADRS-S beräknades genom att göra en ROC kurva relaterad till utfallet av 
PRIME-MD CEG. 
Resultat: Konsultationsmodellen hade goda till måttliga egenskaper för att 
upptäcka mild till måttlig depression i denna population. Flera faktorer; att 
inte ha en partner, att inte ha fritidsaktiviteter, att ha blivit änka/änkling, att 
tidigare ha haft en depression, att ha upplevt livshändelser av betydelse och 
ett regelbundet användande av sömn- och/eller lugnande medicinering var 
associerade med både depressiva symtom och diagnosen mild till måttlig 
depression. Förekomsten av diagnosen mild till måttlig depression var 19 %. 
Att inte ha fritidsaktiviteter var associerat med förekomst av depressiva 
symtom efter två år. Totalt uppvisade alla patienter med mild till måttlig 
depression en symtomreduktion efter två år och tre olika depressionsförlopp 
observerades; förbättrat, stabilt och fluktuerande. Att sänka tröskelvärdet för 
MADRS-S ökade möjligheterna att identifiera mild till måttlig depression i 
denna population.  
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1 INTRODUCTION 
 
I had known L for several years. He was one of those uncomplicated “time-
saving” patients who came in for annual check-ups. I did not know much 
about him except that he was married and was an active man with many 
interests. This time he had made an extra appointment because he felt 
fatigued, had lost eight kilograms and had diarrhea. I found no sign of serious 
illness during the consultation and examination but decided nonetheless to 
start an investigation. The laboratory tests were normal and I saw L 
repeatedly during a three-month period while waiting for the gastrointestinal 
workup results. I was starting to worry that I had missed something serious 
and he was becoming worried because I was worried. We spoke mostly about 
his symptoms, which were unchanged although his weight had stabilized. 
The results of the workup arrived and everything looked fine, except for 
some minor pancreatic calcifications. I called a surgeon I knew and he 
advised me to try prescribing pancreatic enzymes to see if the diarrhea would 
stop, which it did, but L still felt fatigued and drained of energy. At this point 
I had almost given up and finally asked him somewhat resignedly, “Is there 
anything else you would like to tell me?” He was silent for a minute and then 
thoughtfully began to describe some recent life events that bothered him and 
that he couldn’t stop thinking about. Gradually during the consultation, we 
agreed that his fatigue, loss of energy and weight loss could be symptoms of 
depression. He started medication and his symptoms disappeared. At about 
the same time, several articles were published criticizing GPs for poor 
recognition of depressive disorders. With L in mind, I felt that this criticism 
was unfair, and that the authors lacked knowledge of the primary care (PC) 
context and how we work. 
Depression is a syndromal diagnosis with no available biological marker; 
diagnosis is based on a clinical interview in which symptom severity, 
duration and effects on functional ability are assessed according to the 
Diagnostic and Statistical Manuals (DSM) or International Classification of 
Diseases (ICD) classification systems (1). Approximately 5-10% of PC 
patients have a current depression and there is considerable co-morbidity 
with other psychiatric diagnoses, especially with anxiety disorders (2). 
Depression is 2-4 times as common in women as in men. Most patients with 
depressive disorders of various severity are seen in PC and only a minority 
are referred to psychiatric specialists (2-5).The knowledge that individuals 
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with a history of depression have an increased risk of premature death 
underlines the fact that it is a serious public health problem and that the 
management and assessment of depressive disorders are important aspects of 
PC (2). 
 
2. Background 
2.1   Primary Care  
Primary care (PC) is the level of care considered to be the cornerstone in 
many countries’ health services (6). It is usually the point of first medical 
contact for people in the community, providing open and unlimited access 
and dealing with all kinds of health problems. The PC  context and core 
values are rooted in the bio-psycho-social model according to which each 
patient is unique and patients’ physical and emotional health should be 
understood based on social, cultural and existential dimensions related to 
their respective life-stories (7-8). PC should deal with the most common 
problems in the community, it should integrate care when there are many 
problems involved, it should address and understand the context in which the 
illnesses exist and influence, promote and improve health and well-being for 
the individual (6). 
In 2002, the World Organization of Family Doctors (WONCA) defined the 
discipline of general practice/family medicine, as well as its professional 
tasks and required competence.  The following are among the characteristics 
of the discipline:  Efficient use of health care, person-centered approach,  
unique consultation process establishing relationship over time,  longitudinal 
continuity,  specific decision-making process determined by the prevalence 
and incidence of  illness in the community, manages both acute and  chronic 
health problems and illnesses which present in an undifferentiated way,  
promotes health and well-being (7). 
The statement  “ We are not doctors for particular diseases, or particular 
organs, or particular stages in the life cycle-we are doctors for people.” is one 
definition of  a general practitioner (GP) in a PC context (9). 
PC has proven to be beneficial for population health through several 
mechanisms. In addition to being the first health service contact and an entry 
point to the rest of the health care system, as mentioned above, it contributes 
to the quality of care, especially for common conditions, and has significant 
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impact on prevention and early management of health problems.  A 
professional relationship with a GP, characterized by high continuity, is 
associated with patient satisfaction, better compliance and lower 
hospitalization (10). 
In Sweden, PC plays a key role in the prevention, diagnostics and treatment 
of common diseases and health problems.   Swedish GPs have five years of 
specialist training, among the longest specialization programs in the world 
(2). In recent years the previously rather uniform Swedish PC organization 
has changed. Patients used to “belong” to a neighborhood Primary Care 
Center (PCC) and most PCCs were publicly run. While all PC is still publicly 
funded and patients pay a low fee, more privately run alternatives are 
available today. This structural change was intended to strengthen patients’ 
influence on the health care system and increase the individual’s freedom of 
choice. However, patients are required to be “listed” at a privately or publicly 
run PCC.  Irrespective of the organization a  PCC should offer high 
accessibility with professional assessments of level of care; continuity in 
contacts with the GP and/or the PC team; comprehensive, evidence-based 
treatment regimens; referrals to other health services if needed; support to  
patients with social problems; promotion of health and prevention of disease 
(11). 
2.2   The diagnostic process in primary care 
Knowledge of the PC context and the conditions under which clinical 
decisions are made is essential for understanding the complexity of the PC 
diagnostic process. There is a constant process of ruling out medical 
conditions and prioritizing among several competing problems, allocating 
time and attention to the detection and treatment of diseases that are common, 
serious and treatable (12-13). 
The patient-centered consultation method commonly used in Sweden is 
originally from England. It was spread throughout Europe and is now used all 
over the world (14-15). The methods chronological structure is easy to follow 
and understand, balancing the patient’s  and physician’s views of the illness 
(16). In the opening phase of a consultation, which includes an appropriate 
greeting, a relationship between the patient and the doctor is created by 
letting the patient talk without interruption. During this initial phase, the 
doctor explores the patient’s conceptions, fears and expectations regarding 
the health problem and then presents a summary of the patient’s narrative. 
The doctor asks complementary questions, performs a medical examination 
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and translates all this information into a medical perspective on the illness. In 
a negotiation process, the patient and the doctor then communicate their 
respective views and agree on a model of the illness  including both diagnosis 
and a treatment plan (16). Patient-centered care has been shown in several 
studies to be beneficial both to patients and doctors and is positively 
associated with patient satisfaction, adherence and better health outcomes 
(16-17). 
The diagnostic process is an important part of, and runs continuously 
throughout, the consultation. It starts with the patient’s narrative providing 
clues to what might be wrong, leading to the emergence of possible 
diagnoses, and ends in a categorizable result. Diagnostic work consists of 
working with individual patterns and clues towards the non-individual 
category of a diagnosis. Medical diagnosis is  based on the patient’s history 
alone in > 70 % of the cases (18). The context and chronological order in 
which a patient presents his/her illness story provides more information on 
which to base the diagnosis than just a list of symptoms. Sometimes there is 
instant recognition of a disease or of patterns, making the diagnostic process 
quick, but usually the process includes repeated assessments over time, 
including specific medical tests. The outcomes of the diagnostic process are 
classification of the illness, deciding on treatment preference and assessing 
prognosis (18). For GPs, these clinical approaches are a part of everyday 
practice and integrated in their professional role (7). 
2.3   Classifications of psychiatric disorders 
Before World War II, classification of psychiatric disorders was mainly based 
on experiences and observations of patients in mental hospital wards. During 
and after the war, the need for further classifications emerged, as well as   a 
need to record  statistics in psychiatric care (19). In 1952, the American 
Psychiatric Association developed the first standard classification; the DSM 
I. It was followed by the DSM II, DSM III, DSM III-R, DSM IV and DSM 
IV-TR in 1968, 1980, 1987, 1994 and 2000, respectively. A new revision, 
DSM V, is planned in May 2013.  Simultaneously and with similar updates 
and revisions, the ICD was developed by WHO, facilitating diagnostics in PC 
(20-22). 
It is natural that diagnostic classifications change over time, mirroring 
prevailing knowledge and cultural perceptions/influences. Classification 
systems are clinically applicable  worldwide as  tools providing the best 
current guidance and  support in the diagnostic process They are adapted to 
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the demands of psychiatric care and used as instruments for differential 
diagnosis, therapy and research  (21, 23-24). 
2.4   Classification of depression 
The DSM diagnostics system is a criteria-based categorical framework. A 
diagnosis of depression requires the existence of a defined number of 
symptoms, implying clinically significant impairments in the patient’s 
function.  The criteria-based symptoms for major depression were introduced 
in the DSM III (1980); at least five symptoms are required for diagnosis (25). 
The criteria for minor depression were introduced in the DSM IV (1994) 
(26), for research purposes. Two to four symptoms and no history of 
depression are required for diagnosis. In the case of both major and minor 
depression, the symptoms must have been present “most of the day”, almost 
“every day” for two weeks and one of the symptoms must be depressed 
mood or decreased interest/pleasure (DSM IV-TR) (27-28). The criteria for 
these diagnoses are based on consensus rather than empirical evidence; 
consequently,  the  boundaries between depression and the absence of  
depression are  arbitrary (2).  
The ICD-10 system is frequently used in Sweden and, depending upon the 
number and severity of symptoms, a depressive episode is classified as mild, 
moderate or severe ( without or with psychotic symptoms, in the latter case). 
In addition to severity, the depressive episode’s  implications for function are 
also categorized, serving  as a basis for choice and evaluation of treatment 
(2).The two diagnostic systems, DSM and ICD, are not identical and have 
different characteristics. In clinical practice they have limited comparability 
and the boundaries between the different terminologies are arbitrary. To aid 
the clinician,  a “moderate and severe” ICD depression is considered to be 
roughly the same as a DSM “major depression”(29)  and a “mild” ICD 
depression the same as a DSM “minor depression” (2). 
2.5   Depression and primary care 
Several studies confirm that GPs are much better in ruling out depressive 
disorders than in recognizing them but that they fail to identify up to 50% of 
patients with a current depression. Patients were more likely to be recognized 
and treated if they had a more severe depression, more functional disability, 
co-morbid anxiety or if the GP had knowledge of earlier depressive episodes 
(2-3, 30-31). Assessing the level of disability and making diagnostic and 
treatment decisions, focusing on patients with greater impairment, is essential 
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in GPs (32). Diagnostic accuracy and recognition improve when GPs make 
re-assessments at subsequent visits (33). 
When it comes to depression, there are several underlying factors 
contributing to low detection rates,  related to  GPs, patients and the structure 
of the PC system (34). GPs must consider many diagnoses in a short time.  If 
patients fail to provide  any “clues” indicating  mental disorders, the 
identification rate will be low (35). GPs have been criticized as being 
unskilled and lacking knowledge, based on the assumption that the 
psychiatric diagnostic criteria   should serve as the  “gold standard” for PC 
(8). The validity and reliability of this assumption have recently  been 
questioned since the criteria do not always identify common psycho- 
pathological overlapping conditions that exist along a spectrum of anxiety, 
depression and somatization (36-37). In psychiatric care, patients are usually 
selected whereas patients attending PC are unselected, with undifferentiated 
symptoms. They tend to be less severely depressed, the course of the illness 
is milder and the symptom profile is dominated by somatic symptoms (34-
36). Patients presenting with exclusively  somatic symptoms  are more likely 
to be overlooked by GPs (38)  and the PC system structure  may support the 
belief that reporting somatic symptoms is a more legitimate reason for 
seeking care (34, 39). Many patients may prefer a medical explanation for 
their symptoms  (35), failing to  recognize that they may be suffering from 
depression,  and may also hesitate to reveal their psychosocial problems to 
the GP (35). 
2.6   Depressive disorders in the elderly  
Elderly adults are usually defined as aged 65 years and up (40) and are 
sometimes divided into two age groups; “younger elderly” (65-74 years)  and 
“older elderly” (75 years and up) (41). In recent years,  the increasing number 
of elderly adults in the population, the introduction of selective serotonin 
reuptake inhibitors (SSRI) and  increased knowledge of the public health 
impact of depressive symptoms in the elderly have led to  increased attention 
and focus, especially in research, on clinically important depressive disorders 
in the elderly that do not meet  the criteria for major or minor depression (29, 
42-43).These disorders are called  sub-syndromal, mild depression or sub-
threshold depression and differ from minor depression in that the symptoms 
are of short duration and are not always present “most of the day, almost 
every day” (27, 43).  
The categorical criteria of the DSM IV are the current “gold standard” for the 
diagnosis of depressive disorders in the elderly (44). Due to the heterogeneity 
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of depressive disorders late in life, several authors consider the conditions to 
be a continuum in a larger spectrum of depressive disorders defined by 
severity, duration and number of symptoms. In these authors’ opinion, 
affected individuals move in and out of the diagnostic subtypes over time. 
According to this more dimensional view, sub-threshold, minor and major 
depression are clinical variants or different manifestations of the same illness 
(45-50), a view supported by genetic findings in which  families with a 
history of minor or sub-threshold depression have  increased vulnerability to 
depression (51). 
Assessing disability is included in the diagnostic criteria for depression. To 
be disabled is to have difficulties  performing necessary activities of daily 
life, including  personal care or life activities (52-53).This includes mobility, 
looking after oneself, household maintenance and psycho-social functioning 
(54).WHO has developed a self-rated disability assessment schedule 
(WHODAS II) (55) for assessing activity limitations and  restrictions, 
irrespective of medical diagnosis. The domains consist of understanding and 
communication, getting around, self-care, getting along with people, life 
activities and participation in society.  Co-existing somatic diseases, common 
in this population, additionally increase the risks of disability in household, 
family and social life (54). 
2.7   Clinical characteristics of mild to moderate depression in the elderly 
Most elderly patients with depressive disorders are seen and treated in PC 
(42, 56-58). Diagnosing and distinguishing true depression from “normal” 
short term reactions or confounding conditions caused by concomitant 
medical disorders, medications, aging, loneliness, emotionally stressful 
events or grief is especially difficult in the elderly (13, 59-61). Many 
symptoms of depression may be overlooked by the GP’s or the patient’s 
attributing the symptoms to  illnesses or to normal aging (60). 
The symptoms of mild to moderate depression are heterogeneous and the 
most typical, including sadness or depressed mood, may be absent in elderly 
individuals. They may also have fewer symptoms than required for normal 
diagnosis but still have a significant depression (62-64). Late-life depression 
has been called “depression without sadness”, relating to patients who report 
depressive symptoms but who deny sadness or depressed mood. This 
condition was found to be associated with increased risk of death, significant 
functional impairment and psychological distress in a follow up study (62-63, 
65). A recent study of cluster symptom profiles of milder depressive 
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disorders supports this concept, finding that “sadness” was not the most 
severe symptom in elderly patients (66). 
 Unexplained somatic symptoms; feelings of hopelessness, anxiety and 
worry; loss of interest in activities; memory complaints and irritability are 
clinical clues indicating depression in patients who do not present sadness as 
the core depressive symptom (62, 67-68). Concomitant somatic illness, 
anxiety, visceral sensations, difficulty in communicating emotional distress 
(alexithymia) and cultural differences are predictors of depression being 
presented with somatic symptoms (69-71). 
There is a high co-existence of anxiety, albeit not fulfilling any anxiety 
syndrome criteria, in elderly patients with depression. These patients describe 
themselves as tense and, feeling uneasy and nervous. They worry without 
obvious reason. The symptoms of depression and anxiety overlap and are 
sometimes referred to as “anxious depression“ (46, 57, 63). These conditions 
are associated with more severe depressive symptoms and disability and are 
more likely to be identified by GPs (72-74). 
 Irritability (especially in men), increased or decreased appetite, weight loss, 
lack of energy, fatigue, sleep disturbances and joint pain are other important 
symptoms of mild to moderate depression (41, 46, 62-63, 67). Complaints of 
memory loss and poor concentration, with difficulties  watching TV, reading, 
participating in conversations and making trivial decisions, are other such 
symptoms (2). 
2.8   Epidemiology  
2.8.1 Prevalence, age and gender  
The prevalence of depressive disorders not meeting the full criteria for major 
depression among the elderly in PC settings ranges between 10 % and 34%, 
depending on diagnostic criteria and methodology. These disorders have been 
found  to be at least 2-3 times more prevalent than major depressive disorders 
(75). Studies show lower prevalence in European PC settings than in the US, 
possibly reflecting differences in  settings and criteria  (75). Another reason 
for this diversity in prevalence is that several diagnostic instruments are not 
adapted to PC (76). 
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There is a general opinion that less severe depressive disorders increase with 
age and that more severe depressive disorders decrease with age (29, 40, 52, 
77). A recent study demonstrates that there is a more complex relationship 
between age and depression, in which  chronic somatic disease and functional 
limitations play important roles as mediators (78).This study also suggests 
that the relationship between more severe depressive disorders and age is u-
shaped, with prevalence decreasing at ages 65-79, followed by an increase 
depending on how depression is defined. 
Mild to moderate depression is more common in elderly women than in 
elderly men (29, 79) with a prevalence ratio in PC settings ranging between 
2.1 and 3.4:1 (29, 75). In very elderly populations, these gender differences 
are less prominent (29). 
2.8.2   Risk factors 
The burden of a chronic medical disorder that limits activities increases the 
risk of developing a mild to moderate depression (29, 80). It is not so much 
the illness in itself that predicts the onset of depression but rather the 
limitations patients may perceive to affect their “locus of control” and thus 
their self-perceived health (80).A systematic review revealed that there are 
five key significant risk factors for depression in the elderly: bereavement, 
sleep disturbances, disability, prior depression, and female gender (81). 
Bereavement or widowhood should be followed up with counseling and 
support, especially in men. Whenever older patients complain about sleeping 
problems and/or take hypnotics, GPs should consider a depressive disorder 
(29, 81-82). Other factors associated with increased risk for mild to moderate 
depression are co-morbid anxiety disorders, frequent attendance and, certain 
somatic illnesses such as visual and hearing impairments, Parkinson’s 
disease, cardiac disease, stroke, and cognitive disorders (29, 75, 83-84). 
Several social distress factors are considered to be risk factors for mild to 
moderate depression. These are factors often experienced in later life and 
include stressful life events and changes in social network and social 
activities. A diminished social network with social isolation and loss of social 
activities and support increases the risk for depression. Stressful life events 
such as widowhood, loss of close social contacts, family or neighborhood 
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conflicts, major health problems and hospitalization are also factors 
contributing to elevated risk of depression (29, 48, 56, 75, 79-80, 85-86). A 
recent study showed that “lack of social support” was more strongly 
associated with mild to moderate depression in men. In women, the 
association was stronger for “stressful life events”(87). 
2.8.3   Prognosis and outcome 
The course of the depression, functional ability and mortality are factors 
related to prognosis and outcomes. In longitudinal studies, outcomes are 
often measured in terms of remission, response, recovery, relapse, and 
recurrence. Remission is defined as full improvement both in terms of 
symptoms and function, at the end of the follow-up period. Response is 
usually defined as a > 50 % decrease from baseline symptom scale scores to 
trial endpoint. Response can occur without remission, meaning that a 
significant improvement may yield a high score on the symptom scale, thus 
not fulfilling the criteria for remission. Recovery is a remission that lasts over 
time and relapse is a return of symptoms during remission but before 
recovery. Recurrence is a new episode of depression during recovery (88-89). 
 Patients with mild to moderate depression have poorer outcomes than non- 
depressed patients; the condition seems to have similar negative 
consequences as more severe depression for well-being and function (90-
91).The prognosis deteriorates with increasing age and somatic co-morbidity 
and functional limitations are strongly associated with poor  outcome (58). 
Several of the risk factors for onset of a depressive disorder also predict poor 
prognosis: limited social network, meager social support, perceived poor 
health status, concomitant anxiety, and severe depression at baseline (73, 92). 
Reviews of the prognosis for late-life depression showed that it was poor in 
20-50% of the cases, regardless of how depression was defined at baseline 
and the duration of follow-up. The depression became chronic in about one-
third and the same proportion had short-term remission, while median longer-
terms remission rates were 27-33% in follow up studies (58, 74-75, 83). In 
older patients, remission is often followed by recurrence and the risk of 
recurrent episodes is higher than in younger individuals (58, 93). Several 
authors suggest that the long-term course for a majority of elderly with mild 
to moderate depression is fluctuating, chronic or chronic- intermittent and 
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that the depressive symptoms wax and wane in the same patient,  patterns 
that  become more obvious with repeated measurement over time (47, 58, 75, 
83, 90). The important question is whether any of these patterns are 
associated with increased risk of mortality, not only by suicide but also due to 
somatic disease. A recent almost five-year follow-up study showed that 
patients with persistent depressive symptoms were at  increased risk of dying, 
compared to patients with declining symptoms (94).The incidence of major 
depressive disorders is increased in elderly patients with mild or sub-
threshold depression. Longitudinal data have revealed conversion rates from 
minor to major depression of approximately 8-10% per year (75, 95). More 
severe depression increases the risk of death, especially due to cardiovascular 
disease, in both men and women, whereas milder forms of depression are 
associated with increased mortality in men but not in women (75, 77). 
Mortality due to suicide is almost twice as common in late life than in the 
general population, especially in older men (96). Mood disorder is an 
independent risk factor for suicide and two Swedish studies on patients aged 
>75 years showed that minor depression was associated with elevated risks of 
both  attempted and completed suicide (97-98). 
2.9   Diagnostic and rating instruments 
Several diagnostic instruments are currently available to aid in determining 
whether the patient fulfills the diagnostic criteria for depression.  The 
diagnostic interview in the Primary Care Evaluation of Mental Disorders 
Clinical Evaluation Guide (PRIME-MD CEG) instrument, based on the DSM 
IV criteria, and  is commonly used in PC, for which it was especially 
developed (99). 
 Interviewer-rating scales were originally developed for research and clinical 
purposes in psychiatry, in order to assess depression symptom severity and 
change during antidepressant therapy, when the first antidepressants were 
introduced (100-101). These scales cannot fully encompass the different 
dimensions of a depressive disorder and a diagnostic interview is still 
considered to be the “gold standard” with which they are compared (44).The 
most frequently used interviewer-rating scales are the Hamilton Rating Scale 
for Depression (HAM-D) and the Montgomery Åsberg Depression Rating 
Scale (MADRS)(102). These scales can  be used for screening, establishing 
symptom profiles as well as assessing illness  and treatment effects (100).   
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In recent years, self-rating scales have been increasingly accepted in studies, 
along with growing interest in patient participation in the disease 
management process, and used to assess secondary outcomes related to 
quality of life, psychosocial functioning, medication compliance and the 
patient’s perception of symptom severity (103). Self-rating scales are 
commonly used in PC for screening and/or assessment of severity over time 
and are considered to be cost-effective, brief, feasible, and easy to use (44, 
100, 104-105). Most self-rating scales have been developed from interviewer-
rating scales. When observer-ratings are compared with self-ratings, the 
correlation is modest, reflecting the differences in patients’ and clinicians’ 
perceptions of the illness (101, 103). The patient’s view provides   valuable 
and complementary information on depressive symptoms, severity, and 
functional implications in the diagnostic process, thus also supporting clinical 
decisions and evaluations of treatment outcomes (100, 102, 104-106). 
2.10   Screening  
PC offers unique opportunities to promote health and well-being,  
cornerstones in the context of general practice (7). Screening is considered to 
be secondary prevention aimed at lowering the occurrence and more severe 
stages of a disease. Screening should identify individuals with a disease at a 
time where they will benefit from early diagnosis and treatment (107). A 
screening test is not intended to be diagnostic and a positive finding should 
be confirmed with special diagnostic procedures (108). Some general 
principles should be considered before introducing a screening program. 
Firstly the disease should be an important health problem. It should have a 
high prevalence in the studied population and be the cause of substantial 
morbidity and/or mortality. Secondly, the disease should have a detectable 
preclinical phase.  Thirdly, the natural history and course of the disease 
should be known and adequately understood. This is important when 
evaluating the balance between benefits and costs of a screening program. 
Fourthly, there must be effective treatment available.  Furthermore,  
screening programs must be acceptable, safe, easy to implement, and cheap 
(108-109). 
2.10.1   Screening for depression in the elderly in primary care 
Preventing mood disorders in the elderly is an important undertaking in PC. 
Even in their milder forms, depressive disorders cause substantial suffering, 
including increased risk of morbidity and mortality, both due to suicide and 
somatic disease. Depression meets most of the above mentioned criteria for 
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screening: there are serious consequences, it is common, it has a preclinical 
phase, the natural history is known, and there is effective treatment available. 
There are several screening instruments and screening programs available for 
use in PC. The designs vary but their performances are similar and there is 
little evidence to support any instrument over the other (110-112). It has been 
suggested that the choice of instrument should depend on feasibility, 
administration, time requirement  and the ability to monitor severity or 
response to therapy (112).  Most instruments have been validated in general 
or psychiatric populations and secondarily in the elderly (59). In the elderly, 
many instruments, including some elderly-specific instruments, have 
appropriate properties for screening for major depression but they lack 
accuracy for detection of non-major disorders (27, 42, 52, 68, 113-114).   
These instruments can be self- or interview administered and the design can 
be questionnaire with exclusively yes/no answers or also include a grade of 
severity for each response.  They can have preset cut-off points determined in 
psychiatric context or based on Receiver Operating Curve (ROC) analysis 
(112, 114).The questionnaires can be used routinely  or on clinical suspicion 
of an ailment  within the mental disorder spectrum (111, 115). A positive 
screen should always be followed up by a semi-structured clinician interview 
in order to confirm or rule out a diagnosis of depression, based on DSM 
criteria (116). 
GPs have long been recommended to use validated screening and/or self-
rating instruments in clinical practice to enhance the recognition of 
depression. Currently available findings, comprising several studies and 
meta-analyses, show that screening  leads to a modest increase in recognition 
but fails to yield any consistently positive effects on either younger or older 
PC patients’ management or outcome (32, 116-118). Screening of high-risk 
groups has been one proposed strategy but no data from randomized trials 
supports this approach (119). The use of  screening instruments alone in 
routine PC practice  has little impact on overall detection, management or  
outcomes of depression and is not recommended (117).  If screening is 
supplemented with feedback, diagnostic interviews or collaborative care 
outcome may improve but it remains unclear whether screening is a 
necessary component of these interventions (111, 117-118). 
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2.11 Management and treatments of elderly patients with mild and 
moderate depression in primary care 
Most elderly PC patients prefer to receive help for mental problems and 
emotional distress from their GPs giving PC a strategic position in the 
management of late-life depression (57, 120-122). In recent years, there has 
been  increasing interest in providing integrated collaborative care,  shown to 
be both generally effective and cost -effective, in managing mental health in 
PC (123-124). Integrated collaborative care refers to increased involvement 
of non medical specialists, i.e. PC-based nurses, counselors or psychologists  
working in close liaison with the rest of the PC team. It also includes 
collaboration with specialists in psychiatry. All team members contribute to a 
holistic view and shared understanding of the individual patient (124-125). 
Treatment goals are symptom decline to remission, prevention of relapse and 
recurrence, improvement of function and prevention of suicidal ideation (57, 
126). Findings of two important studies, the Improving Mood-Promoting 
Access to Collaborative Treatment (IMPACT) (127)and the Prevention of 
Suicide in Primary Care Elderly Collaborative Trial (PROSPECT) (122), 
support collaborative care in comparison with “usual care”, showing 
significant reduction of depressive symptoms, suffering and disability in the 
elderly in PC. 
In the Swedish national guidelines for depression, collaborative care is 
considered to be essential to the management of depressive disorders in PC 
(128). The organization should offer evidence-based treatment options 
adapted to and in close collaboration with the patient and his/her needs. In the 
clinical context, collaborative care should be offered as stepped care, the 
cornerstones of which are accessibility, continuity and close collaboration 
and, most important, support from psychiatric health care providers. This 
organization resembles team-managed care for chronic diseases and includes 
PC resources such as specialized nurses and behavioral scientists with 
competence in short-term psychotherapy and psychosocial counseling, as 
well as educational programs for patients and physicians (128). 
Cognitive behavioral therapy (CBT) and interpersonal therapy (IPT) are the 
most common psychotherapies in PC (121, 126). The intention behind CBT 
is to change thoughts and dysfunctional attitudes, focusing on 
accomplishments rather than on negative life experiences (120, 129). IPT 
helps patients break larger problems into smaller components and focuses on 
grief, interpersonal deficits or disputes and role changes in life (120, 126, 
129).  Problem-solving therapy (PST), focusing on the “here and now” and 
helping patients function better using their own resources and skills, is 
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another psychosocial approach in PC (129-130). Supportive therapy entails 
patient education, focus on the patient’s concerns, targeting disability 
problems, frequent follow-ups and accessibility (57, 120, 123, 126). 
The pharmacological treatment of choice is selective serotonin reuptake 
inhibitors (SSRI), recommended to be prescribed with a “start low and go 
slow” dose titration (57, 126). SSRIs are not more effective than older 
antidepressants but better tolerated, with fewer side effects, and safer for 
patients with cardiovascular disease (129, 131). There are no grounds for 
recommending one SSRI over the other and the prevailing advice to 
clinicians is to become familiar with one or two SSRIs and use them as first-
line medication for most patients (129).Treatment should continue for six 
months to prevent relapse. Continuous therapy is recommended in cases with 
recurrent episodes (57, 126, 131). 
Different studies have reported different findings regarding the comparison of 
psychotherapy and antidepressants or combinations of both, making general 
conclusions difficult (121). For moderate to severe depression, a combination 
of medication and psychotherapy is considered more efficacious than either 
form of treatment alone (57, 126, 129-130). For mild to moderate depression 
there are no major differences in effect between psychotherapy and 
pharmacotherapy.  Psychotherapy should thus be an alternative for elderly 
patients who cannot or will not tolerate pharmacological treatment (57, 130, 
132-135). Along with growing evidence that many elderly prefer 
psychotherapy, choice of treatment should be based on contraindications, 
treatment access and patient preferences (124, 135). Self-management, 
physical exercise and “watchful waiting” are also recommended for mild to 
moderate depression (126, 129). 
2.12   Patient-centered consultation  
Many errors in medical practice are due to failure in communication. If the 
patient is not understood from the beginning, there is an increased risk that 
investigation and treatment may go wrong. In PC  the patients are self-
referred and the doctors are available for all types of problems, including 
psychosocial and complex unexplained symptoms (136-138). In this special 
context, where the patient and doctor usually know each other,  and may have 
other relationships in common, for example with other family members, 
communication aims at ascertaining  the reason for the encounter and 
exploring  the patient’s agenda (137). In this long-standing doctor-patient 
relationship, the cornerstone of PC, good communication skills, are crucial 
(136, 139). 
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It is increasingly regarded as important that doctors adopt a “patient-
centered” communication style in the consultation.  The primary goal of  
patient-centered consultation is to establish a clear understanding of the 
patient’s perspective on the problem and to create a therapeutic alliance based 
on trust and co-operation (139). Patient-centeredness has been described in 
different ways in the literature. As early as in 1969, patient-centered medicine 
was described in terms of “understanding the patient as a unique human 
being” (140) and later as  “the physician tries to enter the patient’s world, to 
see the illness through the patient’s eyes”(141). A more comprehensive 
description of the key components in the patient-centered clinical method 
was presented by Stewart et al in 1995 (142-143). The method encompasses a 
number of interconnecting domains, one of which is exploration of the 
patient’s experience of disease and illness, probing the patient’s ideas and 
feelings about the problem, effects on function and expectations regarding the 
consultation. Another domain is trying to understand the whole person, the 
context in which he/she lives, how life and family have been affected and if 
he/she feels understood, both emotionally and intellectually. Common 
grounds for partnership in management should be found, concerning 
problems, priorities, treatment goals  and the patient’s and doctor’s respective 
roles. The doctor should promote health, reduce health risks and detect 
disease early. Enhancing a caring and healing doctor-patient relationship with 
shared power is also essential in the concept of patient-centeredness, as is  
being realistic about  personal limitations and the availability of time and 
resources (136, 144). 
The patient-centered clinical method is designed to understand the patient’s 
illness at all its levels as well as the disease. There is a distinction between 
illness and disease; illness is the patient’s personal experience of the 
sensations, feelings, disabilities and the effect the disorder has on activities 
and relationships at many levels. Disease is the pathological process the 
doctor uses as an explanatory model for illness, “Illness is what you have 
when you go to the doctor; disease is what you have when you’ve seen the 
doctor”(137).  
Both patients and doctors have agendas. The doctor’s agenda is to explain the 
patient’s illness in the context of a possible disease. The key to understanding 
the patient’s agenda is the doctor’s receptivity to cues offered by him/her , 
and the doctor’s behavior in encouraging him/her to express expectations, 
feelings and fears (145). Most consultations start with the patient presenting 
symptoms, which is a form of communication influenced by his/her past 
experience and culture. This type of indirect communication is common in 
general practice(137). The aim of the medical interview is to discover the 
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person behind the symptoms by collecting both verbal and non-verbal 
information concerning the patient’s problem; it does not just consist of 
asking questions and receiving answers. It is which questions are asked, how 
they are asked and how the answers are received that will determine if the 
interview will achieve the goal. The most usual error in medical interviews is 
the failure to listen, with undivided attention and without interrupting, to the 
patient’s story until the patient is done (137). The scope of this rapport 
between doctor and patient is also determined by the doctor’s empathic skills; 
how he/she picks up important cues from the patient and interprets them. 
These “internal” empathic qualities have affective, cognitive and behavioral 
dimensions which complements the clinical assessments (139). 
Every patient who has made an appointment with a physician has some 
expectations of the visit. They are often related to a concern or a symptom 
and may  be expressed very straight forwardly with a question or a request or 
in a more unconscious and subtle ”by the way” manner (146).  Feelings are 
not always expressed spontaneously by the patient. They are often hidden 
under the surface and may emerge during the consultation process but must 
usually be inquired about.  Fear is a universal feeling in the doctor-patient 
interaction. Almost all patients have some fantasy or fear about their illness, 
how it will be managed and what effects it may have on life. Feelings of fear 
can be “here and now” or reflect the patient’s life experiences and past events 
(146). The doctor can  encourage the patient to express expectations, feelings 
and fears  with open-ended questions, open-ended statements, reflections and 
confrontations (146).  
The quality of the communication between doctor and patient in the 
consultation is central for patient satisfaction, adherence and longer-term 
health outcomes (17, 139). Both patients and doctors benefit from good 
communication skills. Doctors identify patients’ problems more accurately 
and patients are more satisfied with their care and understand their problems 
and the planned management better (147). Patients also adjust better 
psychologically, with less distress and less vulnerability to anxiety and 
depression. In addition, doctors report greater job satisfaction and less work 
stress (148). In conclusion, an increased patient involvement in expressing 
concerns and, preferences, as well as  participating in medical decisions, has 
been found to have positive effects on health status, self-management, coping 
behavior, therapeutic compliance and quality of life (149-151).  
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2.12.1   Patient-centeredness and older patients 
Together with education and increased access to modern information, 
increased life expectancy will influence living conditions for older people. 
The traditional view of the elderly is changing and seniors are exhibiting 
similar preferences for health care as younger people, creating challenges for 
health care systems (149, 152). The elderly are a very heterogeneous group, 
differing in their perceptions and needs, as well as in their interest in their 
own health and ability to participate in medical decisions (149, 152). The 
definition of “involvement” is to take an active role in  decisions and 
planning related to  medical care (153). To facilitate “involvement” patients 
should be supported in making decisions regarding health care, they should 
be informed about risks and benefits,  be assisted in making informed choices 
about  diagnosis and treatment and be encouraged to share responsibility for 
their own health (153). Earlier research has shown variability in elderly 
patients’ desire to be involved and participate in medical decisions; not all 
patients want to participate to the same degree.  Several studies have found 
that the elderly were more likely to prefer a physician-directed style of 
decision-making, especially when it comes to treatment (154-156), and that 
preference for an active role in medical decisions seems to decline with 
increasing age (156). In a large European study of elderly patients 
preferences concerning involvement, patients were more focused on the 
patient-centered approach when it came to  building a professional 
relationship and receiving information than in taking an active part in 
decision making (149).They wanted to be involved in their care, offered 
choices and asked about their opinions but made a clear distinction between 
evaluating information and taking responsibility for treatment decisions (149, 
157). Emphasis on the importance of receiving good information during 
consultations was reported in another study (158). Impeding factors for older 
patients’ involvement include feelings of fear, perceived lack of knowledge 
or understanding, low self-esteem and physical or mental disabilities 
including, hearing and vision impairment (149, 153-154). In a systematic 
review, patients with a high degree of preference for involvement were found 
to be younger, have higher education and higher income (155). In one PC 
study of older patients with one or more chronic conditions, high preference 
for involvement was associated with patient enablement, meaning the ability 
to cope with life and illness (159). 
Building a good doctor-patient relationship with  clear and open 
communication, in which  the doctor shows interest and, provides 
information about health conditions as well as on treatment options and 
prevention seem crucial for elderly patients’ preferences in the consultation 
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with their GPs (149). The desire to participate in decision-making is 
heterogeneous and may change over time. An individual and flexible 
approach is recommended, in which the physician devotes major 
consideration to the patient’s autonomy, preferences and goals (149, 153). 
Facilitating factors for patient involvement are related to both the health care 
system and the physician and include high accessibility of health care, 
sufficient consultation time, continuity, the physician’s communication skills 
and the possibility to build a trustworthy relationship  (149, 153-155). 
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3. AIMS OF THE THESIS 
 
3.1 General aims 
The aims of this thesis are to explore and describe the difficulties and 
complexity of detecting and managing elderly patients with milder forms 
of depressive disorders, which are common in PC, and to study the effect 
of a patient-centered approach in the consultation. 
3.2 Specific aims 
Study I 
To describe the prevalence of and to explore factors associated with 
depressive symptoms in an elderly PC population. 
Study II 
To evaluate the performance of a patient-centered consultation model in 
detecting depressive symptoms, compared with a validated screening 
instrument for depression, in elderly PC patients. 
Study III 
To observe the course of an elderly PC cohort with mild to moderate 
depression during a two year follow-up and to investigate risk factors and 
prognostic factors. 
Study IV 
To determine a clinically useful threshold value for a self-rating 
instrument when screening for mild to moderate depressive symptoms in 
older PC patients. 
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4 MATERIAL AND METHODS 
This thesis comprises four quantitative studies, an overview of which is 
presented in Table 1  
Table 1 Methods used in the studies in this thesis. 
 
 
Study 
 
I 
 
II 
 
III 
 
IV 
Design 
Observational 
Cross- 
sectional 
 
Observational 
Cross- 
sectional 
 
Observational 
Longitudinal 
cohort study 
Observational 
Cross- 
sectional 
 
Study groups 
Unselected 
consecutive 
patients  aged 
> 60 attending 
the PCC 
N= 302 
Unselected 
consecutive 
patients aged 
>60 attending 
the PCC 
N= 302 
A cohort of 
patients aged 
>60 with mild 
to moderate 
depression 
N=54 
A cohort of 
patients aged 
>60 
participating 
in  a 
diagnostic 
interview 
N=156 
Data 
collection 
method 
 
Questionnaires 
Interview with 
nurse  
Patient-
centered 
consultation 
model 
Medical 
records 
 
Questionnaires
Interview with 
nurse  
Patient-
centered 
consultation 
model 
 
 
Questionnaires
Interview with 
nurse  
Patient-
centered 
consultation 
model 
Medical 
records 
Questionnaires 
Interview with 
nurse 
Patient-
centered 
consultation 
model 
 
 
Data analysis Descriptive Comparative Follow up Statistical 
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Table 2 Participants; age and gender 
 Women, n (%) Men, n (%) Total, n (%) 
Total 
participants 
Mean age 
207 (69) 
75 SD+ 8.2 
95 (31) 
76 SD+ 8,2 302 (100) 
Age 60-64 
years 24 (12) 11 (12) 35 (12) 
Age 65-74 
years 65 (31) 27 (28) 92 (30) 
Age 75+ years 118 (57) 57 (60) 175 (58) 
 
4.1 Studies (I-IV) 
4.1.1 Design 
This longitudinal study was essentially naturalistic, reflecting “the real 
world” of PC. It was conducted as an integrated part of the PCC’s and the 
participating GPs’ daily work. No extra time and resources was allocated for 
the study except for a part-time study nurse during enrollment. The study 
nurse was subsequently employed at the PCC, making it possible to conduct 
the follow-ups for two years. Data was collected for all papers using 
questionnaires, interviews with a nurse, a patient-centered consultation model 
and medical records. Cross-sectional baseline data was used in all four 
studies. In Paper III data was also collected from repeated questionnaire 
assessments during two years. 
4.1.2. Setting, subjects, inclusion and exclusion criteria 
The study was conducted at Brämaregårdens PCC in Gothenburg, Sweden. 
The PCC served about 15,000 people at the time of the study. In the Lundby 
area, where the PCC is situated, the proportion of people aged 65 years and 
older was 16.3 %, compared with 15 % in the entire city of Gothenburg. The 
inclusion period was between February and December, 2003. Patients aged 
60 and up were asked at the reception desk, consecutively and without 
selection, to participate in screening for depressive symptoms. Patients with 
severe psychiatric diagnoses (severe depression, schizophrenia, severe 
general anxiety disorder, bipolar affective disorder and dementia) were 
excluded. Patients were divided into three age groups: 60-64 years, 65-74 
years and 75 years and up. The intention with including the age group 60 and 
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up was to study sick leave frequency related to depressive symptoms. Two 
GPs and a PCC nurse with psychiatric training conducted the study.  
4.1.3. Instruments and methods 
PRIME-MD 
As mentioned above, the PRIME-MD instrument (99) was especially 
designed for use in PC and covers the most common psychiatric disorders. It 
was developed with financial support from Pfizer Inc. which also financed its 
translation to Swedish by Pär Svanborg, MD, PhD.  
The instrument has two components: a self-administered Patient 
Questionnaire (PQ) with yes/no items plus one five-graded (poor, fair, good, 
very good and excellent) question about perceived general health.  Responses 
to the five-graded question were dichotomized as “good” (good, very good 
and excellent) and “bad” (fair and poor).  The second component is a 
Clinician Evaluation Guide (CEG) which includes different diagnostic 
modules used by the GP to follow up positive screens. The PQ includes two 
screening questions concerning depression (numbers17-18) and three 
questions concerning anxiety (numbers19-21). Five questions about alcohol 
and two concerning pain in conjunction with menstruation and coitus were 
excluded due to previous low response rates (160).  Questions 17-21 were 
used when screening for depression, as anxiety symptoms  often occur 
simultaneously with depression in this age group (73).  Answering “yes” to 
any of questions 17-21 was regarded as a positive screen. Patients also 
answered questions on somatic symptoms and self-rated health. The module 
for diagnosing depression in the CEG is a semi structured DSM IV-criteria 
based-interview, comprising nine yes/no items. The PQ was used in Papers I-
II and the CEG was used in Papers III-IV.  
MADRS-S 
The MADRS-S (161) is the self-rated version of the MADRS (162) and 
consists of  nine items. Patients are instructed to rate symptom severity over 
the three last days, on a 7-point scale (from 0-6). The variables have four 
scale steps with the possibility of scoring half steps: 0-1, 2-3, 4-5 and 6 
points, respectively, yielding a maximum score of 54. The total scores were 
calculated and categorized according to the interpretation  guidelines  
indicating that a MADRS-S score of 0-12 points is no depression, 13-19 is 
mild depression, and 20 points or more is moderate/severe depression (163). 
A MADRS-S score >13 was regarded as a positive screen for depressive 
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symptoms. The MADRS-S was used in Papers I-IV. It is described in the 
Appendix. 
MMSE 
The Mini Mental State Examination (MMSE) (164) is a screening instrument 
for dementia focusing on the cognitive aspects of mental functions. It is 
divided into two parts, the first of which is a questionnaire covering 
orientation, memory and attention. The second part tests the ability to name 
objects, follow verbal and written commands, write a sentence and copy a 
complex polygon figure. The maximum total score is 30 and patients scoring 
below 24 points were excluded due to risk of dementia (164). The screening 
instrument was used in Papers III- IV.  
Medical records 
All patient contacts, including consultations and telephone contacts with 
nurses and GPs, were registered in the computerized medical records at the 
PCC.  Data on diagnoses, ongoing medication and number of telephone 
contacts were manually collected from the records.  Diagnoses were 
registered in the medical records according to the Swedish version of the 
ICD-10 (165). Sedatives were coded according to the Anatomical 
Therapeutic Chemical Classification system (ATC)  (166) as benzodiazepines 
(N05B A, N05C D) and non-benzodiazepine sedatives (N05B B, N05C F, 
N05C M06). Medical records were used in Papers 1 and III. 
Laboratory tests 
Laboratory tests at inclusion in the follow-up study were taken to rule out 
somatic conditions such as anemia, cobalamine deficiency, diabetes, thyroid 
dysfunctions, hyperparathyroidism and infectious diseases (Paper III). 
Interview with the nurse 
The study nurse interviewed the patients with the aim of covering the most 
important socio-demographic and other background data associated with risk 
and prognosis for depressive disorders in the elderly (75). The chosen 
variables were age, sex, socioeconomic and marital status, social network, 
leisure activities, history of depression, current treatment for depression, 
smoking, widowhood, history of serious somatic disease and   significant life 
events during the last year. Marital status was combined into one variable, 
“having a partner” (defined as married, cohabiting or in daily or almost daily 
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contact with a special person)(160). A socioeconomic classification system 
based on the patient’s occupation was used (167-168). The data from this 
interview were used in Papers I-IV. 
Patient-centered consultation model 
Patient-centeredness is a consultation approach for general practice. 
Originally derived from England, it is now in extensive international use and 
is described more thoroughly in the Background chapter of this thesis. The 
patient-centered consultation model in this study is well-established in 
Sweden (16). The model is characterized by a chronological, gradual, 
strategy during the consultation:  exploring the patient’s view of the illness, a 
physical examination and a negotiation concerning diagnosis and 
management. The first step of this model covers a broad range of feelings and 
concerns about what is causing the illness, elucidated  by  a series of key 
questions (169). The GPs used these key questions in the consultation when 
screening for depression in the elderly (Papers I-IV). Every tenth consultation 
was audio-taped to certify that the model was implemented according to 
patient-centered consultation standards. If the patient spontaneously 
presented at least two criteria-based depressive symptoms, one of which was 
either “depressed mood” or “loss of interest” during the consultation, it was 
regarded as a positive screen for depression (i.e. “possible depression”). 
 
 
 
 
 
 
4.2. Procedure, Studies I-II 
Patients accepting participation first met the study nurse for an interview and 
completed the PRIME-MD PQ and the MADRS-S before seeing the GP, who 
was unaware of the results. During the consultation, the GPs assessed 
whether or not the patients had a “possible depression” according to 
instructions. Included patients with a positive screen in the PRIME MD PQ, 
Key questions 
1. What made you come here today? 
2. What do you think your problem is? 
3. What do you think caused your problem? 
4. Are you worried about anything in particular? 
5. What have you tried to do about the problem so far? 
6. What would you like me to do about your problem? 
7. Is there anything else you would like to discuss today? 
                                                                 From Malterud K 
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the MADRS-S or the consultation were given a new appointment for a 
diagnostic interview within two weeks.  
4.3 Procedure, Study III 
The GPs performed the diagnostic interviews, following PRIME-MD CEG 
guidelines. The definition of mild to moderate depression was the presence of 
at least two depressive symptoms, one of which must be either “depressed 
mood” or “loss of interest”. The study nurse conducted the MMSE and 
laboratory tests in included patients, as well as follow-up assessments of 
patients with depression, using the MADRS-S at 2, 4 10 and 22 months from 
baseline. Timing of these follow-ups was adapted to both patients’ and the 
nurse’s summer vacations and holidays. The course of depression was 
defined as remitting, fluctuating or stable; depending on significant changes 
in the MADRS-S scores (see “Method” in Paper III). The medical records for 
patients who were assessed as non-depressed were searched for depressive 
diagnoses (ICD 10; F 32, F33) within two years of the diagnostic interview.  
4.4 Procedure, Study IV 
In order to determine the optimal MADRS-S cut-off point for detecting mild 
to moderate depression in this population, sensitivity/specificity and a ROC 
curve were calculated for different MADRS-S scores, compared with the 
diagnostic status according to the PRIME-MD CEG. The optimal cut-off 
score was defined as the point on the ROC curve where the sum of the 
corresponding sensitivity/specificity pair reached a maximum. 
4.5 Statistical analysis, Papers I-IV 
For Papers I-IV the statistical analyses were performed using the EPI Info 
statistics program, version 3.3.2 (Centers for Disease Control, Atlanta, Ga). 
Furthermore the SPSS-PC version 18 was used for Paper IV. 
Descriptive statistics were used to describe the population in Paper I. Fisher’s 
exact test was used when there were differences in proportions (between men 
and women for variables with small samples in the 2x2 table). The Student’s 
t-test was used when analyzing differences in continuous data and the Mann-
Whitney test was used if data was skewed. Unconditional multivariate 
logistic regression was used for studying characteristics in Paper I. MADRS-
S score >13 was the dependent variable and independent variables were 
different factors at baseline. Age, gender, “having a partner” and social 
network were independent variables except when they were the event of 
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interest. When analyzing diagnoses and medication, perception of good 
health was added as an extra independent variable. 
Sensitivity and specificity, positive predictive value (PPV) and negative 
predictive value (NPV) were calculated for the consultation model and the 
PRIME-MD PQ, with  two cut-off levels for MADRS-S (>13and >20) as  the 
reference (Paper II). 
Unconditional multivariate logistic regression tested the association between 
different factors at baseline and the diagnosis of depression according to the 
DSM IV. Two years later, the different factors at baseline were tested with 
logistic regression using MADRS-S score >13 as the dependent variable. 
Adjustment for age and gender were included as independent variables in all 
logistic regressions (Paper III).  
Estimating test performance and the optimal MADRS-S cut-off score in 
relation to a DSM IV diagnosis of depression was calculated in a ROC 
analysis (Paper IV). 
4.6 Ethical considerations 
Ethical approval for the studies was granted by the Regional Ethical Review 
Board in Gothenburg, Sweden (Dnr 055-03). Ethical principles based on the 
Helsinki declaration were followed. All patients received both verbal and 
written information about the study aim and procedures. All participants gave 
written informed consent and they were informed that they could withdraw 
from the study at any time for any reason without any consequences 
concerning care. A data file was set up and each patient was numbered: the 
link between number and personal information was only known to the main 
researcher. All participants were informed that information concerning them 
would be handled confidentially and that no information would be traceable 
to a single individual. 
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5 RESULTS 
5.1 Patient characteristics (Paper I) 
All 302 patients aged 60 and up who attended the PCC during the study 
period agreed to participate (participation rate 100%). The population 
consisted of 207 women with a mean (standard deviation (SD)) age of 75 
(8.2) years and 95 men with a mean (SD) age of 76 (8.2) years. The group 
aged 60-64 years was the smallest (n=35) and that aged 75 years and up was 
the largest (n=175). There were 92 patients in the group aged 65-74 years. 
Most patients were skilled and unskilled workers. None of the patients aged 
60-64 years were on sick leave.  
The point prevalence of depressive symptoms, defined as a MADRS-S score 
>13 at baseline, was 15 % (n=46) and most common in the youngest age 
group. There were no significant differences between the high- and the low-
score groups when it came to socioeconomic status, previous telephone 
contacts or common medical diagnosis in the elderly. The use of 
sedatives/hypnotics was significantly associated with higher MADRS-S 
scores. Seventy percent of the patients scoring MADRS-S >13 used 
benzodiazepines and/or other sedatives/hypnotics on a regular basis. 
A previous history of depression, widowhood and a significant life event 
were risk factors for scoring MADRS-S >13. Several somatic symptoms i.e. 
gastrointestinal problems, fatigue, insomnia, back pain and dizziness were 
associated with scores above threshold value (MADRS-S >13) and “having a 
partner”, leisure activities and perceiving one’s health as good were 
associated with scores below the threshold value. 
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Table 3 Age and socio-economic status for all patients and for patients with 
MADRS-S score >13. 
 All patients MADRS-S score >13 
Characteristic Women 
n (%) 
Men 
n (%) 
Total 
n (%) 
Women 
n (%) 
Men 
n (%) 
Total 
N (%) 
Age, years       
 60-64 24 (12) 11 (12) 35 (12) 8 (33) 3 (27) 11 (31) 
 65-74 65 (31) 27 (28) 92 (30) 11 (17) 3 (11) 14 (15) 
 75> 118 (57) 57 (60) 175 (58) 17 (14) 4 (7.0) 21 (12) 
Total participants 207 (69) 95 (31) 302 (100) 36 (17) 10 (11) 46 (15) 
Socio-economic groupa       
 Ib 6 (3.0) 3 (3.2) 9 (3.1) 2 (33) 0 (0) 2 (22) 
 IIc 78 (39) 41 (44) 119 (40) 10 (31) 2 (5) 12 (10) 
 IIId 117 (58) 50 (53) 167 (57) 23 (20) 8 (16) 31 (19) 
a Missing data for seven patients, N=295 
b Comprising large-scale employers and officials of high or intermediate rank. 
c Comprising small-scale employers, officials of lower rank and foremen. 
d Comprising skilled and unskilled workers. 
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5.2 Patient-centered consultation (Paper II) 
The properties of the patient-centered consultation model and the PRIME-
MD PQ were calculated using the MADRS-S as a reference. The patient-
centered consultation model exhibited moderate sensitivity and specificity, 
78% and 81%, respectively, at the cut-off point MADRS-S > 13. At the cut-
off point MADRS-S >20, the sensitivity and specificity were 93% and 75%, 
respectively. Ten patients of 46 scoring >13 on MADRS-S were not 
identified by the GPs in the clinical consultation.  
At the lower MADRS-S cut-off point, the screening questions for depression 
in the PRIME-MD PQ had sensitivity and specificity rates of 98% and 54%, 
respectively. At the higher MADRS-S cut-off point, sensitivity was 93% and 
specificity was 48%. Adding the questions about anxiety to the depression 
questions in the PRIME MD PQ increased the sensitivity, but not the 
specificity, at both MADRS-S cut-off points.  
The PPV was higher for the patient-centered consultation model than for the 
PRIME-MD PQ and 85 patients  of 302 patients (28 %) were assessed as 
having a possible depression, compared with 162  of 302 patients (54%) with 
the PRIME-MD PQ. NPV was high both for the consultation model and for 
the PRIME-MD PQ at both MADRS-S cut-off levels. 
Table 7 Test characteristics for the PRIME-MD PQ and patient-centered 
consultation; depressive symptoms defined by the reference MADRS-S score 
>13.a 
 Sensitivity 
 % 
Specificity  
% 
PPV  
% 
NPV 
% 
Consultation, GP’s 
assessment 
78 (66-90) 81 (76-86) 43(32-53) 95 (93-98) 
Prime-MD 17-18 98 (94-100) 54 (48-60) 28 (21-35) 99 (98-100) 
Prime MD 17-21 100 52 (45-58) 27 (20-33) 100 
    a Prevalence of depressive symptoms was 15%. 
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5.3 The two-year follow-up (Paper III) 
A total of 177 patients screened positive with any of the three screening 
methods. Two patients died (of somatic causes in close connection to 
screening), two were hospitalized for somatic illness and four declined 
participation. Thus, 169 participated in a diagnostic interview (see flowchart). 
Ten patients were excluded due to other psychiatric diagnoses, including 
dementia. Fifty-seven patients were assessed as having a diagnosis of mild to 
moderate depression:  the point prevalence of mild to moderate depression 
was 19 % (57/302). Three patients declined further participation and the 
remaining 54 patients, 41 women and 13 men, were included in the follow-up 
study. During the two-year follow-up, 51 patients completed five MADRS-S 
assessments, including the baseline assessment.  There was a reduction in the 
median MADRS-S scores and a remitting, stable or fluctuating course was 
seen in 29%, 49% and 22% respectively.  Concerning choice of treatment, 
antidepressants were initiated in 25 patients, 22 patients wanted more 
frequent follow-ups with their GPs, four patients wanted psychological 
treatment and three patients preferred a combination of antidepressants and 
psychological treatment. Of the included 54 patients, 23 reported depressive 
symptoms as the reason for the consultation. The reasons for the remaining 
21 patients were distributed as follows:  follow-up of chronic disease (n=6), 
musculoskeletal symptoms (n=7), gastrointestinal symptoms (n=4) and 
“miscellaneous” (n=14). 
Factors associated with a depressive diagnosis at baseline were “not having a 
partner”, widowhood, significant life events, lacking leisure activities, a 
history of depression and use of sedatives/hypnotics. Back pain and fatigue 
were symptoms associated with depression. For every additional reported 
somatic symptom in the PRIME-MD PQ, the odds ratio (OR) for a 
depressive diagnosis increased (OR 1.4, 95% CI 1.2-1.6, p<0.0001). Lacking 
leisure activities at baseline was associated with depressive symptoms 
(MADRS-S >13) two years later. Of the 102 patients who were not assessed 
as having a depression, the medical records during the same follow-up period 
showed that 76 did not have a registered depressive diagnosis; 11 had 
ongoing antidepressant medication, suggesting a chronic course of 
depression: and a new episode of depressive diagnosis was registered for 13. 
One patient died and one patient developed dementia during the follow-up 
period and was not evaluated. 
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Table 8 Factors and symptoms at baseline associated with baseline 
prevalence of depressive diagnosis according to the DSM-IV (PRIME-MD) 
(N=156) 
Variable OR 95% CI p -value 
”Having a partner” 0.41 0.20-0.85 .02 
Have not become widowed  
during last year 
0.11 0.02-0.57 .009 
No leisure activities 3.4 1.4–8.2 .006 
No significant life event  
during the last year 
0.32 0.15-0.67 .0025 
No history of depression 0.40 0.19-0.80 .0099 
Perception of good health 1.5 0.94-2.3 .09 
Socio-economy 1.0 0.56-1.9 .94 
Medication    
Sedatives, benzodiazepines 2.0 1.0-4.0 .051 
Sedatives, non-benzo- 
diazepines 
3.8 1.9-7.8 .0002 
Lipid-lowering medication 0.48 0.17-1.4 .17 
Symptoms    
Stomach ache 1.2 0.56-2.6 .65 
Back pain 2.1 1.0-4.3 .041 
Chest pain 1.6 0.76-3.2 .22 
Dizziness 1.2 0.61-2.4 .60 
Palpitations 1.5 0.72-3.1 .28 
Dyspnea 1.1 0.53-2.3 .79 
Constipation or diarrhea 1.4 0.69-2.9 .35 
Fatigue or loss of energy 4.4 1.5-13 .009 
Insomnia/hypersomnia 1.5 0.76-2.9 .25 
Change of appetite 2.6 0.65-10 .18 
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Table 9 Factors and symptoms at baseline predicting prevalence of 
depressive symptoms two years later, defined by MADRS-S score > 13 
(N=51) 
Variable OR 95% CI p -value 
”Having a partner” 1.7 0.30-9.6 .55 
No leisure activities 12 1.1-136 .041 
No significant life event  
during the last year 
0.51 0.05-5.2 .57 
No history of depression 0.17 0.02-1.6 .12 
Perception of good health 1.9 0.52-6.7 .34 
Socio-economy 0.43 0.09-2.0 .29 
Medication    
Sedatives, benzodiazepines 1.1 0.20-5.6 .94 
Sedatives, non benzo-  
diazepines 
2.8 0.47-17 .26 
Lipid-lowering medication 3.8 0.11-133 .47 
Symptoms    
Stomach ache 0.9 0.14-5.7 .90 
Back pain 0.65 0.11-3.9 .64 
Chest pain 0.43 0.07-2.6 .36 
Dizziness 1.6 0.32-7.6 .58 
Palpitations 0.98 0.19-5.0 .98 
Dyspnea 0.80 0.13-4.8 .81 
Constipation or diarrhea 0.96 0.15-6.1 .97 
Insomnia/hypersomnia 2.0 0.34-12 .44 
Change of appetite 1.3 0.11-15 .84 
  
 
Table 10 Reasons for initial visit 
Variable Total N =54 (%)
Check-up of chronic disease 6 (11)
Musculo-skeletal symptoms 7 (13)
Depressive symptoms 23 (43)
Gastrointestinal symptoms 4 (7)
Miscellaneous 14 (26)
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Figure 2. Median MADRS-S scores 
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5.4 Evaluation of the MADRS-S (Paper IV) 
Twenty-six of 54 patients (48 %) with mild to moderate depression had 
MADRS-S scores >13, yielding   a sensitivity of 48 % and a specificity of 91 
% for this instrument, using a pre-determined cut-off value. The ability of the 
MADRS-S to discriminate mild to moderate depression from no depression 
on the individual level in this population was examined by calculating the 
area under the ROC curve, using data from the 156 patients accepting 
participation who were not subsequently excluded.  The area under the ROC 
curve was 0.77, (95% CI 0.68-0.85). The optimal MADRS-S cut-off point 
was determined to be 8/9, as sensitivity and specificity were 77% and 69 %, 
respectively. Using the post-hoc ROC curve cut-off value, MADRS-S >9, 42 
of 54 patients (78%) with mild to moderate depression were correctly 
identified. 
Table 11 Age, socioeconomic status and MADRS-S scores for all patients 
 All patients   N= 156 
Characteristics Women (n=119) n (%) 
Men (n=37) 
n (%) 
Age, years   
 60-64  16 (13) 4 (11) 
  65-74 38 (32) 9 (24) 
 75+ 65 (55) 24(65) 
Socioeconomic group*   
       I a 4(3) 0 (0) 
       II b 45 (39) 15 (41) 
 III c 68 (58) 22 (59) 
MADRS-S>13 29 (24) 6 (16) 
MADRS-S <13 90 (76) 31 (84) 
Depressive diagnosis n=54 41 (35) 13 (35) 
* Missing data for 2 women (n=117) 
aComprising large-scale employers and officials of high or intermediate rank. 
bComprising small-scale employers, officials of lower rank and foremen. 
cComprising skilled and unskilled workers. 
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6 DISCUSSION 
Summary 
In this unselected elderly PC population, all patients agreed to participate in 
different screening procedures for depressive symptoms. The point 
prevalence of depressive symptoms, defined as a MADRS-S score >13 at 
baseline, was 15 % and the point prevalence of mild to moderate depression, 
according to the DSM IV, was 19 %. Several psychosocial factors and 
somatic symptoms were significantly associated with MADRS-S scores >13. 
Patients with ongoing treatment for depression and patients who perceived 
that they were in good health did not have elevated scores. Patients in the 
high-score group had considerably more somatic complaints than those 
scoring below the cut-off point but there were no differences between these 
groups in the frequency of visits or telephone contacts prior to inclusion. The 
MADRS-S was used as a reference when comparing the psychometric 
properties of the PRIME-MD PQ and the patient-centered consultation model 
in screening for mild to moderate depression in this population. The 
sensitivity of the PRIME-MD PQ was higher than that of the consultation 
model but the PPV was lower, yielding a high number of false positives. The 
consultation model had lower sensitivity and failed to identify every fifth 
patient but the PPV was higher, reducing the required number of diagnostic 
interviews by almost 50%, compared to PRIME-MD PQ. Both procedures 
had high NPVs, indicating excellent properties in ruling out depressive 
symptoms. The PRIME-MD CEG was used in the diagnostic interview and 
patients assessed as having mild to moderate depression were followed-up for 
two years. Several assessments with the MADRS-S were made during 
follow-up. While mean MADRS-S scores declined over time, half of the 
patients had a stable course, almost one third had a remitting course, and the 
rest had a fluctuating course. The characteristics of patients at risk of mild to 
moderate depression corresponded with those of patients with MADRS-S 
scores above the cut-off point. The variable “lacking leisure activities” was 
also a prognostic factor for poor outcome in the follow-up. A majority of 
patients reported various reasons, including somatic symptoms, for the initial 
encounter and there was an increased risk of depression for every additional 
somatic symptom reported by the patients in the PRIME-MD PQ. The 
MADRS-S instrument exhibited limited accuracy in screening for mild to 
moderate depression with a preset cut-off value. A post-hoc ROC curve 
analysis cut-off value increased the performance of the instrument and the 
ability to distinguish mild to moderate depression from no depression. 
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6.1   Methodological considerations 
All papers derived from a longitudinal study and each paper had its own 
design.  
Study I was a descriptive study of an elderly population in an urban area of 
Gothenburg. Recruiting patients consecutively with few exclusion criteria led 
to a high inclusion rate. Many patients had had active contact with the PCC 
for years and can thus be considered representative for a PC population in the 
area. In the unconditional multivariate logistic regressions, the outcomes 
were adjusted for age, gender, “having a partner” and social network, based 
on the assumption that these factors are possible confounders for depressive 
symptoms in the elderly. When diagnoses and medication were the focus of 
interest, we also added “perception of good health” as a possible confounder.  
The analysis showed the respective associations of the different variables 
with depressive symptoms. The use of cross-sectional data did not allow any 
cause-effects interpretations (170). The high participation rate and the 
demographic characteristics suggested that the findings were representative 
of Gothenburg and that they may also be generalized to an urban Western 
European population. One nurse with psychiatric competence performed the 
screening procedures and interviewed all patients, which may have been 
beneficial for data collection consistency. The interview with the nurse 
covered most factors that might have influenced the onset of depressive 
symptoms.  It is possible that these factors might have been elucidated even 
more if we had also used a validated general health questionnaire focusing on 
function and perceived health in association with depressive symptoms.  
Study II was a comparative study. Assessment of the psychometric properties 
of a screening procedure for depression should be compared with a “gold 
standard”, at present a diagnostic interview according to the DSM IV(44). A 
weakness of this study was that we did not perform a diagnostic interview 
with all patients during the first visit and that we used a MADRS-S score 
above a preset cut-off point as the reference when evaluating the 
psychometric properties of the PRIME-MD PQ and the consultation model. 
A MADRS-S score above the cut-off point indicated a depressive disorder 
but the diagnosis had not yet been verified. The accuracy of rating scales, 
regardless of whether they are interviewer-rated or self-rated, is difficult to 
determine, as there is no “gold standard”(104). The interviewer-rated 
MADRS and the self-rated MADRS-S are considered to be complementary, 
as correlations are only moderate to good, indicating that the patients’ and the 
physicians’ perceptions of the disease differ. It is unclear whose perceptions 
are more valid (101-104).The patients were screened with the PRIME-MD 
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PQ and the MADRS-S before seeing the GPs, which may have affected 
results by making them more willing to address depressive symptoms during 
the consultation. The key questions in the consultation model did not 
comprise any specific question on depression, which may have been a 
limitation. On the other hand, GPs perceiving patients to be “psychiatric 
cases” was shown in one study to be a valid marker for major depression in 
PC patients (115). In another study, the use of a “help” question, similar to 
one of our key questions, improved detection rates (171). Every tenth 
consultation was audio-taped and the tapes were evaluated by an independent 
researcher to minimize the risk of preconceptions and to certify that the 
model was used according to patient-centered consultation standards.  
Another limitation of this study was the low number of participating GPs and 
that we did not compare GPs using and not using the consultation model. 
Study III was an observational longitudinal study with frequent follow-ups of 
patients with mild to moderate depression during two years. The use of three 
screening procedures for depressive symptoms, minimizing the risk of 
missing patients with a depressive disorder during enrollment, and the fact 
that very few patients withdrew from the study were strengths.  A positive 
screen was followed up with a diagnostic interview, using the PRIME-MD 
CEG, within two weeks from the initial encounter, which may have affected 
the results since the instrument is designed to be completed during the initial 
consultation. Using the two-staged PRIME-MD instrument on one occasion 
is sometimes considered to be too time-consuming to be clinically useful and 
it is common in research to complete the PRIME-MD on one occasion and to 
perform the diagnostic follow-up interview at a later date (172-173).This later 
follow-up may be beneficial for patients with milder depressive disorders, 
increasing the possibility to reconsider and re-examine symptom severity, 
thus avoiding over-diagnosis (4).The fact that we did not perform any 
diagnostic interviews during follow-up, making it difficult to assess 
remission, recovery and symptom duration, was another weakness in this 
longitudinal study. Furthermore, other prognostic factors might have been 
revealed if we had performed diagnostic interviews during the last encounter. 
Our definition of the different course patterns, based on median MADRS-S 
scores, was an observational undertaking, not analyzed with formalized 
statistics. The small sample size and the use of mean MADRS-S scores to 
describe the course, due to solitary outliers’ disrupting interpretation, are 
other limitations.  
The longitudinal design yielded a dynamic view of the condition over time. 
Furthermore, multiple follow-ups better reflect the course of depressive 
symptoms, compared to fewer follow-ups (58). It is possible that quality of 
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life assessments, now recommended in follow-up studies, would have 
reflected functional outcomes (e.g. emotional recovery, well-being and 
functional status), in addition to symptom-based outcomes (174-175). 
Study IV was a post-hoc ROC curve analysis determining the optimal 
MADRS-S cut-off point for acceptable sensitivity and specificity rates in this 
population. A systematic review showed that most studies based their 
sensitivity and specificity calculations on cut-off points determined by post-
hoc ROC curve analysis, possibly overestimating test performances, 
compared to studies using preset cut-off points (114).The choice of cut-off 
point depends on the purpose and in which context or population the 
instrument is to be used (176). One limitation of the ROC curve analysis is 
that there is always a “tradeoff” between sensitivity and specificity at the 
expense of specificity. Utility aspects concerning who will be missed and 
who will be detected require consideration (176).  
Screening instruments 
In this thesis, the PRIME-MD PQ was chosen for screening because it is 
brief, easily self-administered with yes/no alternatives and starts out with 
several somatic symptoms, common in the elderly, that we wanted to study in 
association with depressive symptoms. It is not designed especially for the 
elderly but studies have shown test characteristics to be stable in different age 
groups (110).The exclusion of the questions regarding alcohol is a limitation 
of this study, as they might have revealed additional information about this 
population had they been included. The current version of the Swedish 
PRIME-MD instrument refers to 28 questions in the PQ, whereas there were 
26 questions in the original version. We used the original 26-question 
version. The statement in the Methods section in Papers I and II that a 28- 
question version was used is thus erroneous. However, this did not affect the 
numbering of the questions included in the studies. The PRIME-MD CEG 
thresholds for a diagnosis of minor or major depression were 2-4 and > 5 
symptoms, respectively, following DSM IV criteria (99, 177). In this thesis, 
the definition of mild to moderate depression was based on the ICD-10 
classification system. Since the ICD-10 and the DSM IV classification 
systems are not identical, we defined mild to moderate depression as 
corresponding to minor depression and major depression of medium severity. 
The MADRS-S instrument served two purposes in this thesis, screening and 
follow-up. It was chosen for its briefness, psychometric properties, 
acceptability to patients and sensitivity to change (102-105). Both the GPs 
and the nurse were familiar with the instrument. The MADRS-S closely 
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follows the DSM criteria for depression and focuses on core psychiatric 
depressive symptoms. It contains few somatic items and can measure 
depressive symptom severity independently from personality (101, 161, 178). 
As it does contain few somatic items, the instrument is less sensitive to 
physical disease, which is common in the elderly. Applying the MADRS-S in 
an elderly population may therefore be advantageous when assessing milder 
forms of depression with overlapping somatic symptoms (179). A limitation 
of this instrument is that it is not designed to identify minor or sub-threshold 
disorders (161). 
The most common screening instrument for depression in the elderly in PC is 
the Geriatric Depression Scale (GDS) (180). We decided not to use this scale 
for several reasons. Although it has good properties for screening for major 
depression, it lacks accuracy when screening for non-major depressive 
disorders, our focus of interest (114). Several of the somatic symptoms that 
we wanted to study in association with depression were not covered by GDS 
items and the diagnostic reliability of the Swedish PC version (GDS-20) is 
considered to be uncertain (1).  
6.2 General discussion 
For many years there has been a focus on improved detection and 
management of elderly patients with depressive disorders, even in milder 
forms, because of the elevated risk for serious consequences, including 
increased mortality related to suicide, somatic illness and cognitive 
impairment (2, 46, 181). A majority of older patients who commit suicide 
have seen a GP one month prior to their death (182). Today, there are 
effective treatment options available and management can be adapted to 
resources, individual values and preferences. Detecting and managing mood 
disorders in the elderly are important preventive issues in PC, in order to 
increase function and quality of life as well as decrease costs for and 
demands on health care systems (75). Findings from these studies may 
contribute to the understanding of both the onset and the course of milder 
forms of depressive disorders in elderly PC patients, which may in turn 
increase the possibility of prevention, early detection, diagnosis and 
appropriate management. 
The study population and the PCC 
Most patients who were asked to participate in the studies were familiar with 
the PCC. Very few patients met the exclusion criteria; they were either well 
known or attended psychiatric care. The participating GPs were experienced 
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and had worked many years at this particular PCC. It is possible that the 
patients’ familiarity with both the PCC and the GPs contributed to the 100 % 
participation rate. Another explanation for the high participation rate was that 
several patients expressed a genuine interest in participating in a “local” 
study. A high participation rate was also seen in another PC study of similar 
design (171), and the willingness to participate may also reflect the 
acceptance of the diagnosis of depression, as seen in other studies (125). The 
high participation rate and the demographic characteristics suggest that our 
findings are representative of Gothenburg and may also be generalized to a 
general urban Western European population. Both GPs had been involved in 
supervising medical students and were well acquainted with the patient-
centered consultation model used in the studies. They were both women and 
one is the author of this thesis, which may have affected the patient-centered 
consultation outcomes, due to special interest in the subject. 
Despite the fact that depressive symptoms were most common in the age 
group 60-64 years, none of the patients were on sick leave, making it 
impossible to study sick leave frequencies. There was a 30-year age span in 
the population, reflecting a substantial heterogeneity in the term “elderly”. 
The patients’ living conditions are probably very diverse and some baseline 
variables may be more or less relevant for the individual, depending on age. 
Many factors are not only associated with age but also related to changes in 
society. With higher life expectancy there is an increasing number of elderly 
who have higher education, are more physically and mentally active, and are 
expected to work longer, indicating that assessing “functional age” rather 
than chronological age may be important in the future (93). Even if the age 
group 75+ was the largest in this population, results might have been 
different and more age-specific with a larger number of patients in each age 
group and if age groups had been evaluated separately. More women than 
men participated in the study, as has  been seen in other studies, possibly due 
to women’s higher life expectancy and more frequent PCC visits (94, 183). 
The classification system on which the socioeconomic evaluation was based 
is old but still in use (167-168). A majority of patients belonged to 
socioeconomic groups II and III, and strikingly few women, equally 
distributed among socioeconomic groups II and III, had been homemakers 
and thus classified according to their husbands’ occupations. 
Prevalence 
Calculating the point prevalence of depressive symptoms, using cross-
sectional MADRS-S scores >13 at inclusion, did not reveal whether it 
represents the early or late stages of a more severe depression, reactions to 
6758
xiv 
upsetting life events, or symptoms of medical illness (184). However, the 
point prevalence of mild to moderate depression, calculated after the 
diagnostic interview, may be more accurate. The higher point prevalence of 
mild to moderate depression was probably due to the application of three 
different screening methods during enrollment, minimizing the probability of 
missing patients with any depressive symptoms. These findings correlate well 
with earlier studies, although there is a diversity of prevalence rates in the 
literature, depending on methodology and diagnostic criteria (29). 
Risk factors and prognostic factors 
We found that both female gender and history of depression were risk factors 
for MADRS-S scores above the cut-off point and for a diagnosis of mild to 
moderate depression. Cross sectional studies on risk and prognostic factors 
limit cause-effect interpretations. A recent meta-analysis suggests that some 
of the studied variables might be more clear-cut risk factors (e.g. female 
gender), while other conditions might be both risk factors for and a 
consequence of mild to moderate depression (75). This should be considered 
when interpreting our finding that the variable “leisure activities” was 
associated with MADRS-S scores >13 at baseline as well as with a diagnosis 
of mild to moderate depression. However, it was also a prognostic factor for 
MADRS-S scores > 13 after two years. Our interest in leisure activities, 
defining as “participating in at least one stimulating activity outside the 
home” was merely based on clinical experience. When asked about decreased 
interest/pleasure, one of the core symptoms of depression, many patients 
answered quite distinctly that they had stopped participating in any activities 
outside home, activities that they had used to enjoy. There are additional 
dimensions to outside activities, including the effort of leaving home and the 
social dimension of meeting other people. Stimulating and pleasurable 
activities at home are obviously also of interest, but possible interactions with 
diminished interest in other daily life activities may lead to less specific 
evaluation. The variable “having a partner” was developed during the 
inclusion period because many elderly people preferred to live separately, but 
nonetheless considered themselves to be partnered. As one of the 
participating women said, “I like spending time or traveling with him but I 
still want a place of my own”. “Not having a partner” was associated with 
both depressive symptoms and a diagnosis of mild to moderate depression. 
Being unmarried has previously been shown to be associated with sub-
threshold depression in late life (75). 
“Significant life events during the last year” was associated with both 
depressive symptoms and a diagnosis of mild to moderate depression, 
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whereas somatic illness during the last year was not. Distinguishing somatic 
illness from significant life events was aimed at targeting psychological 
stressors in the context of life events. We did not use any specific 
questionnaire for this assessment, but the nurse was instructed to inquire 
about events affecting quality of life such as illness in the family, separations, 
deaths and interpersonal problems outside or within the family. Many of 
these life events are known risk factors for depression in the elderly and for 
suicide (185-186). Replacing the question “How are you?” with “How is your 
family?” may help GPs explore the role of family factors in late-life 
depression. Supporting our findings, a longitudinal follow-up study in 
Finland showed that several psychosocial factors such as life events, changes 
in close relationships and giving up hobbies were related to the occurrence of 
depression, in both men and women (187). 
Most patients perceived their own health as “good”; this was associated with 
significantly decreased MADRS-S scores at baseline, and there was no 
association with either depressive diagnosis or depressive symptoms after 
two years.  The variables “having leisure activities”, “having a partner” and 
perceiving one’s health to be “good” may be protective factors against mild 
to moderate depression and promoters of well-being in the elderly. This may 
be important information for both health care systems and the community.  
Older people use less health and social services if they have higher levels of 
emotional, social and psychological well-being (188). Poor self-rated health 
predicts depression (189). Perception of health, one of the main factors 
influencing overall well-being, was defined as “being able to continue doing 
the things they had always done” in one recent study on people aged >65 
(188). Efforts aimed at investigating the needs and interests of older people 
and encouraging them to maintain and develop their social activities and 
networks may improve health and function and minimize the risk of 
depressive disorders (188). A recent meta-analysis on psychosocial 
interventions for prevention of depression in older adults showed that social 
activities significantly reduced depressive symptoms, compared to non-
intervention controls (190).  
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The use of sedatives and hypnotics 
The frequent use of sedatives and hypnotics and the strong association with 
both elevated MADRS-S scores and depressive diagnosis were “eye-openers” 
for the two participating GPs. In addition to known side effects including 
cognitive impairment and ataxia, leading to falls and fractures, this may also 
indicate under-recognition and/or poor management of depression and 
anxiety, as has been shown in earlier studies (191).In a study on associations 
between benzodiazepine use and mental disorders in older PC patients, many 
users suffered from depressive and/or anxiety disorders and had been using 
benzodiazepines for years (191).In the Västra Götaland region in western 
Sweden, increasing attention is being focused on changing prescription 
patterns regarding sedatives/hypnotics for older patients and financial 
incentives have been introduced to encourage PCCs to follow guidelines. 
Gradual tapering off of medication, psychological interventions and SSRI 
prescription have proven effective in discontinuing long-term benzodiazepine 
use and are recommended whenever possible, in order to improve functioning 
(192). 
The presentation of somatic symptoms 
In PC, patients are essentially unselected and single somatic symptoms are 
the primary reason for more than 50% of the visits (193-194). Somatic 
symptoms as the reason for the encounter are sometimes considered to be “a 
ticket into the system” (34). Assessing whether a physical complaint is due to 
somatic illness or a depressive disorder is a complicated diagnostic dilemma 
for GPs (194). In the elderly, who usually have somatic co-morbidities, this is 
especially difficult. There is some evidence, both from qualitative and 
quantitative studies, that GPs believe all other causes of somatic symptoms, 
especially fatigue and anorexia, must be ruled out prior to considering a 
depressive diagnosis (69). 
Earlier PC studies have found that only 25-30% of the patients with 
depression present purely depressive symptoms as the reasons for attending 
(69, 194). In this study, almost half of the patients reported depressive 
symptoms as the reason for the encounter, which may reflect the interactions 
between the patients and the GPs. It is possible that longstanding professional 
relationships made the patients more willing to communicate and reveal 
symptoms of psychological distress. This is supported by findings from a 
study in which the probability of a somatic presentation of depression was 
higher in “drop-in” settings, compared with those in which the physician had 
a professional relationship with the patients (34). 
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Associations between somatic symptoms and depression in the elderly have 
been reported previously (69-71, 193). This supports our findings that several 
somatic symptoms were associated with elevated MADRS-S scores and some 
(e.g. back pain and fatigue) with a depressive diagnosis as well. Some 
symptoms associated with high MADRS-S scores (e.g. chest pain, 
palpitations and dyspnea) may reflect concurrent anxiety, which is closely 
associated with depression, especially in the elderly (75). The overall risk for 
a depressive diagnosis increased with every additional somatic symptom 
reported, as seen in other studies (194-195). It has been suggested that if GPs 
adopt a more “inclusive approach” and suspect a depressive diagnosis 
whenever several and unexplained somatic symptoms are presented, 
especially repeatedly, interventions might prevent a more severe and chronic 
course of the illness (69, 194-196).  
Patient-centered consultation and screening for depression   
There is growing evidence that patients who are encouraged to participate 
more actively in their own medical care have better outcomes (149). A 
review on interventions involving older people in PC showed some positive 
effects on specific methods but none that could be recommended for daily 
practice (153). The structured patient-centered consultation model used in our 
study in screening for depressive symptoms was aimed at exploring the 
patients’ expectations, feelings and fears about the reasons for the encounter, 
encouraging active participation in the consultation. Our key questions are 
well integrated in the consultation model and can target any medical problem. 
Irrespective of the presented problems, they may disclose symptoms of 
psychological distress meeting the criteria for a depressive disorder. The GPs 
were concerned that the key question “Is there anything else you would like 
to discuss today?” might reveal problems that could not be solved within 
consultation time limits. Instead, this question seemed to be important in 
enabling the expression of psychological distress, thus contributing to the 
assessment of core depressive symptoms. In his ”A Textbook of Family 
Medicine”, Ian McWhinney (137) calls this the “exit problem” or the 
“doorknob comment ”, as patients often leave the most sensitive problem, 
usually the main reason for the consultation, to the last. 
Balancing true positives with true negatives (e.g. sensitivity and specificity) 
in a screening procedure is important. In the case of the consultation model, 
sensitivity and specificity rates were moderate but the balance between them 
was better than for the PRIME-MD PQ. To be of clinical use, especially in 
PC, sensitivity and specificity should be complemented with PPV and NPV. 
PPV is the probability that the disease is present if the test is positive and 
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NPV is the proportion of those testing negative that are truly disease-free. 
Both PPV and NPV are highly dependent on the prevalence of the disease, as 
well as on sensitivity and specificity (170). A low prevalence will yield low 
PPV and high NPV, increasing the number of false positives but favorable 
for identifying non-depressed patients (4).This was seen in our study, both 
for the consultation model and the PRIME-MD, when the higher MADRS-S 
cut-off point was applied and the prevalence was low. At the lower MADRS-
S cut-off point, the prevalence rose and the number of false positives was still 
high for the PRIME-MD, but it was reasonable for the consultation model, 
decreasing the number of diagnostic follow-ups by almost 50 %. In the case 
of depression, it has been hypothesized that there is a tipping point at a 
prevalence of 27 % where the number of false positives meets the number of 
false negatives, underlining the impact of prevalence on detection rates (4). 
Both the PRIME-MD and the consultation model had excellent properties in 
ruling out depressive symptoms at both cut-off levels, supporting earlier 
findings that many screening instruments are better suited for exclusion than 
for inclusion purposes (76, 110). 
A recent meta-analysis assessed GPs’ clinical diagnosis of depression in 
routine PC practice, unaided by severity scales, diagnostic instruments or 
educational interventions (4).The weighted diagnostic sensitivity was 50.1 % 
and the weighted diagnostic specificity was 81.3 %; at a prevalence of 21.9 
%, the PPV was 42 % and the NPV 85.8 %. In comparison, the sensitivity for 
the consultation model in our study was higher and the PPV was about the 
same at a prevalence of 15 %. At the lower cut-off level for the MADRS-S, 
the consultation model missed one in five patients. At the higher cut-off 
level, indicating more severe depressive symptoms, the consultation model 
failed to identify one in ten patients. The finding that more severe cases are 
identified more reliably than less severe cases is consistent with other studies 
(197-198). Diagnostic sensitivity has been suggested to be improved with a 
better therapeutic relationship, familiarity and contact with the patients, as 
well as with increasing experience in the GP (4, 198). The GPs in our studies 
were experienced, had long-standing professional relationships with many of 
the participating patients and had offered continuity of care for many years. 
This, together with the GPs’ awareness of the studies’ aim, may have 
contributed to the relatively high detection sensitivity rates for the 
consultation model. The question of whether it is the consultation model or 
the GPs’ ability to “sniff out” depressive symptoms that was actually 
measured in this study can be discussed. Alone or in combination with two 
questions on depression a question resembling one of the key questions was 
asked in a PC study aimed at detecting depression: “is this something with 
which you would like help?” Sensitivity and specificity rates for this question 
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alone were 75 % and 94 %, respectively (171). Another more recent study, 
using this same “help” question found no corresponding increase in 
sensitivity but findings did suggest that the “help” question could facilitate 
discussion about mood disorders and their management in the PC context 
(199). 
The PRIME-MD and screening for depression 
We found that the PRIME-MD PQ had some limitations in screening for 
depressive symptoms in this elderly PC population. Although sensitivity and 
NPV rates were high for the depression questions as well as for the 
combination of the depression and anxiety questions, specificity and PPV 
were low, resulting in a high number of false positives, as also seen in other 
studies (110, 171). Screening instruments with high false positive rates are 
not feasible or cost-effective for use in PC, as they create huge workloads in 
the follow-up process. The participants in our studies seemed to be 
comfortable filling out the questionnaire (PQ) and all answers were 
interpretable. Early on, Spitzer et al recognized several limitations of the two-
staged PRIME-MD instrument for use in clinical practice. The instrument has 
been altered to a single self-administered questionnaire, the PRIME-MD 
Patient Health Questionnaire (PHQ), in which the response categories are 
expanded to measure severity with the ability to monitor outcomes over time, 
resembling other self-rating instruments more (172). However, the PRIME-
MD CEG seemed to be a valuable tool for diagnostics in primary care.  
The MADRS-S in clinical practice 
The MADRS-S was originally presented as one of three subscales from the 
psychiatric Comprehensive Psychopathological Rating Scale, Self-Affective 
(CPRS-S-A). The cut-off point for mild depression was set at >13, based on 
clinical psychiatric observations and two normal samples (163). In recent 
years, this cut-off point has been lowered to >12 (179). Many patients in 
these studies did not reach the MADRS-S cut-off level of >13 for mild to 
moderate depression. Almost twice as many patients had a positive screen for 
depression in the PRIME-MD PQ, to which they responded first. Our 
suggested explanation is that grading symptom severity with the MADRS-S 
made the patients reassess their perception of the reported depressive 
symptoms in the PRIME-MD PQ, as if they were thinking, “Maybe I don’t 
feel so bad after all”. The nurse identified a few questions that seemed more 
difficult for the patients to answer. One of them was about “pessimism”, 
which has two dimensions in Swedish, one regarding the future and one 
relating to guilt. This was confusing and required clarification by the nurse. 
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This confusion was also seen in the original MADRS-S study (200). The 
question concerning “zest for life” made some of these elderly patients feel 
uncomfortable. 
The MADRS-S exhibited limited properties as a screening instrument for 
depressive symptoms in this elderly population when the preset cut-off point 
of>13 was applied according to the original guidelines. Only about half of the 
patients with mild to moderate depression had MADRS-S scores >13, 
indicating that this cut-off level may be too high in this population. When a 
post–hoc ROC analysis cut-off value was applied, the MADRS-S 
performance increased, but there was still a risk of missing patients suffering 
from clinically significant depressive disorders. Our findings suggest that the 
MADRS-S may not be useful for screening for mild to moderate depression 
in elderly PC patients, regardless of whether preset or post-hoc cut-off values 
are applied. This is in accordance with the recommendations that wating- 
room screening should not be undertaken in PC (1, 117). 
However, using the MADRS-S in the follow-up study seemed feasible and 
useful for evaluating treatment outcomes. None of the patients withdrew 
during follow-up, indicating high acceptance, which was also seen in another 
study (103). Asking patients to rate their perception of depressive symptoms 
over time also increased their opportunity to participate more actively in 
treatment and management decisions, key components in the definition of 
“patient involvement” (153).This might also have improved the patients’ 
ability to identify separate symptom components, increasing their 
understanding of their illness (104). Although the MADRS-S is not 
developed for use in PC and does not address older people specifically, the 
self-rating scale may be useful in supporting clinical decisions and be of 
therapeutic value by involving patients in follow-up assessments   (1, 102). 
Course of depression 
Studying the course of mild to moderate depression might help identify the 
patients most at risk of persistent depression.  The strategy of dividing 
patients into subgroups based on the type of course might provide important 
signals indicating when to intervene (201). In these studies over almost two 
years, we found three patterns of depressive symptoms. The first pattern 
consisted of median baseline MADRS-S scores substantially over the cut-off 
point, with a marked remitting course. These patients had probably responded 
well to their choice of therapy and maybe considered not to be at risk of a 
persistent depression. Interpretations should be cautious for the stable and 
fluctuating course types, for which median MADRS-S scores did not reach 
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the pre-set cut-off value at any assessment which is normal to guidelines. 
Nonetheless, these patients were assessed as having a clinically significant 
mild to moderate depression at the diagnostic interview. Possible reasons for 
this discrepancy are that the MADRS-S instrument, originally developed for 
psychiatric care, is not valid in this population and that the recommended cut-
off value was too high. Patients not reaching the median cut-off level might 
have had a “depression without sadness”(62), thus not captured by MADRS-
S, or persisting sub-threshold symptoms “ waxing and waning” within the 
same spectrum of depressive disorder. In addition MADRS-S is not a 
diagnostic instrument. These patterns may require special attention since the 
specific characteristics of individuals in the different groups are unknown. 
We do not know who will have an increased risk of persistent depressive 
symptoms or who will have a self limiting course. However, a recent study 
(PROSPECT) of course patterns suggests that patients who are unmarried, 
aged under 70 years and have several co-morbidities may need special 
attention for improvement of depressive symptoms, as they are at increased 
risk of persistent depressive symptoms and poor long-term outcomes (201). 
The total median MADRS-S scores declined and it is possible that the 
follow-up encounters and continuity per se may have prevented milder forms 
of depression from deteriorating in this cohort, an effect seen in other studies 
(202). The observed change could also be due to the regression towards the 
mean phenomenon (203).  Despite these declining scores, almost 20 % had a 
chronic course, defined as having MADRS-S scores >13 at 80 % or more of 
the observations, indicating that the prognosis is generally poor in this sub-
group, findings confirmed by other studies (90, 204). 
Is depression over-diagnosed? 
GPs can both overestimate and underestimate depressive symptoms and it is 
unclear which is most problematic in routine clinical practice (4, 198). While 
there is longstanding debate about GPs’ under-detection of depression in PC, 
some authors argue instead that depression in PC is over-diagnosed. The 
condition is heterogeneous and GPs have implemented psychiatric diagnostic 
methods in response to symptoms that may resemble those of a depressive 
disorder but that mainly emanate from normal problems in everyday life 
(205). In the international discussion, there is a conflict between those finding 
it important to diagnose milder forms of depressive disorders in the elderly, 
in order to increase quality of life, and those advocating cautiousness in 
diagnosing and treating disorders that may be natural adaption to age. The 
latter fear that the side effects of treatment with modest efficacy (e.g. 
medication) can worsen rather than improve the situation for the aging person 
7566
xxii 
(2, 205).The risk of overestimation of depressive symptoms is highest in 
those with known risk factors for depression. The clinical significance of 
over-recognition is highly dependent on what happens after the diagnosis, i.e. 
does the GP initiate treatment, “watch and wait” or re-assess? (4). In order to 
increase the rate of correct diagnosis and improve overall quality of care, GPs 
should adopt a stepped care approach, with repeated re-assessments of 
patients suspected of having depression, a core approach in the PC context (4, 
33, 205-206). 
“Gold standard” 
 A “gold standard” is the best and most accepted reference method to 
establish the presence or absence of a disease or illness (207). “Gold standard 
“and “the truth” are not always the same. Recently, there has been a 
discussion on the validity and relevance of DSM IV criteria in a PC context. 
The criteria were developed based on the demands of psychiatric care. The 
resulting categorical approach in which the psychiatric syndromes are distinct 
from one another, does not cover all categories of clinically significant 
depressive disorders, especially sub-threshold disorders which are frequent in 
PC and in the elderly (4, 46). There is emerging consensus on viewing 
depressive disorders as a continuum, agreeing on clinical continuity between 
very mild and more severe depressive disorders that may share 
characteristics, onset variables as well as functional and psychosocial 
consequences (46, 50, 75). Moving towards a more dimensional approach to 
diagnostics, as proposed in the DSM V, and diagnosing depressive disorders 
using DSM criteria may be more clinically meaningful for PC physicians.  
Management of depression in primary care 
It has been suggested that, rather than spending time on screening procedures, 
GPs should focus on improving the care of those who have already been 
identified as well as on the sub-groups of depressed patients most vulnerable 
to recurrent episodes (208-209). There are several available evidence-based 
treatment and management options with similar outcomes (210). Since the  
majority of elderly individuals with mood disorders are diagnosed and treated 
in PC, the important question is how available resources should best and 
most cost-effectively be organized in PC to meet the need of  both patients 
and professionals (211). In effectively managing depressive disorders in the 
elderly, PC settings can be visualized as a ship where all crewmembers must 
collaborate,  contribute  and strive in the same direction to deliver 
professional and high-quality care. Continuity, accessibility and collaborative 
care are key components in improving quality of care, outcome, patient 
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satisfaction and adherence (2, 128). Continuity of care involves stepped, 
collaborative team care models, including integration of psychiatry specialists 
in conjunction with self-management adapted to individual patient 
preferences, needs and values (128, 212-215).  High accessibility for a first 
assessment is essential in the management of mood disorders (128, 210-211). 
In recent years there has been a focus on accessibility in Swedish PC, leading 
to improved telephone systems and an increasing number of short “drop-in” 
visits. It is not obvious that these “improvements” benefit the elderly with 
depressive disorders. Patients may be reluctant to address a mood disorder 
during short consultations, especially if they lack a professional relationship 
with the GP (35) and the telephone may be a barrier due to difficulties in 
hearing and following instructions. A majority of people aged 65 years or 
older have one or more chronic illness and the health care system must 
balance unscheduled “drop-in” visits with planned management of chronic 
illness (216). In improving the care of patients with depression, chronic care 
models may be beneficial for long-term management of selected groups 
(208). These models include linkage with community-based resources, self-
management support, decision-making support from evidence-based 
guidelines and proactive teamwork with feed-back systems within the PCC 
(216). Offering the patient a special “contact person” may be one way to 
secure accessibility, continuity and trust. 
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7. CONCLUSION 
Most elderly patients with milder forms of depression are seen and managed 
in primary care. They are important to recognize since these conditions are 
associated with increased mortality and morbidity related to suicide, somatic 
illness and cognitive impairment. Several treatment options are available. 
Increasing function and quality of life and preventing the development of 
more serious or chronic courses of depression are key issues for primary care. 
Knowledge of risk factors, prognostic factors and course, implementation of 
a structured patient-centered consultation model, and adjustment of screening 
or rating instruments’ cut-off values may be helpful for GPs in detecting, 
assessing and managing depressive disorders in elderly primary care patients. 
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8. FUTURE PERSPECTIVES 
Comparison of a larger number of GPs using the structured patient-centered 
consultation model at different PCCs with GPs not using the model is one 
challenge for the future. This would hopefully elucidate the implications of 
the patient-centered approach for detection, management, adherence to 
treatment, course, and outcome as well as patient involvement, quality of life, 
and perceived health. Another future perspective is the introduction of a 
proactive and preventive approach in close collaboration with the 
community, investigating the needs and preferences of elderly individuals to 
create opportunities for developing and/or maintaining social activities, 
networks and continuing “doing the things they have always done” (188). 
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